You are here


Vision, Mission, & Role

Primary tabs


Engaged partnerships benefitting research, innovation and public health


To enable and guide collaboration, invention development and licensing to advance today's discoveries into tomorrow's medical care


The NCI TTC serves as the focal point for implementing the Federal Technology Transfer Act to utilize patents as incentive for commercial development of technologies and to establish research collaborations and licensing among academia, federal laboratories, non-profit organizations, and industry.  TTC supports technology development activities for the NCI and nine other NIH Institutes and CentersBecause the NIH is a Federal government entity, it cannot commercialize or manufacture its discoveries. However, TTC proactively facilitates partnerships with outside organizations so that these discoveries can reach the public. TTC:

  • Negotiates co-development agreements and licenses with universities, non-profit organizations, and pharmaceutical and biotechnology companies to ensure compliance with Federal statutes, regulations and NIH policies.
  • Reviews Employee Invention Reports (EIRs) and makes recommendations concerning filing of domestic and foreign patent applications.
  • Negotiates transactional agreements with outside parties, including universities, pharmaceutical and biotechnology companies to ensure compliance with Federal statutes, regulations and NIH policies and facilitates commercialization efforts to benefit public health.
  • Provides guidance to intramural and extramural scientists on all technology transfer matters
  • Provides advice, guidance, and assistance on the development and management of intellectual property
  • Proposes and implements innovative development strategies and academic and industry partnerships for NCI technologies, as well as for those from Institutes and Centers served by TTC.
  • Serves as liaison with individuals, committees, and organizations within and outside the Federal Government who are interested or involved in matters relating to technology transfer.
  • Provides guidance on handling extramural inventions for which the grantee has declined title
  • Negotiates of co-development agreements, including CRADAs, MTAs, CTAs, and CDAs
  • Reviews, tracks and reports on all active cases, patent licenses and royalties
  • Trains Intramural Research Program staff in matters of technology transfer related to their official duties
  • Serves as liaison to allied offices, such as the NIH Office of General Counsel
Tuesday, March 17, 2020